靜脈輸液幫浦市場規模、佔有率和成長分析（按產品、疾病、應用和地區分類）－2026-2033年產業預測

全球靜脈輸液幫浦市場規模預計在 2024 年達到 175.4 億美元，從 2025 年的 189.4 億美元成長到 2033 年的 350.6 億美元，在預測期（2026-2033 年）內複合年成長率為 8%。

全球靜脈輸液幫浦市場正經歷強勁成長，主要促進因素包括慢性病盛行率上升、人口老化以及醫療技術的創新。這些關鍵的醫療設備能夠確保將液體、藥物和營養物質精準地輸送到患者的血液中。居家醫療服務需求的不斷成長以及臨床環境中對精準給藥的需求，正顯著影響著市場。此外，減少用藥錯誤和提高病人安全性的日益重視，也進一步加速了市場擴張。靜脈輸液幫浦產業的未來取決於開發出使用者友好、互聯互通且注重病患安全和治療效果的設備。持續整合數據驅動技術和以患者為中心的設計，預計將透過滿足醫療專業人員和患者不斷變化的需求，塑造市場趨勢。

全球靜脈輸液幫浦市場促進因素

癌症、糖尿病和心血管疾病等慢性病的發病率上升，以及全球人口老化，正顯著推動靜脈輸液幫浦的需求。這些關鍵設備在為長期照護患者精準輸注藥物、液體和營養方面發揮著至關重要的作用，有助於更好地管理疾病並改善健康結果。隨著越來越多的患者尋求長期護理，對高效靜脈輸液系統的依賴性也日益增強，凸顯了這些設備在現代醫療保健環境中的重要性。

全球靜脈輸液幫浦市場限制因素

全球靜脈輸液幫浦市場面臨許多挑戰，其中最主要的原因是先進型號的高成本。除了初始購置費用外，持續的校準、維護和人員培訓等費用也會對醫療預算造成沉重負擔。這種經濟壓力對醫療機構構成重大障礙，尤其是在資源匱乏、資金緊張的地區。這會阻礙這些關鍵設備的普及，並影響預算緊張地區患者照護品質。因此，必須認真考慮成本問題，才能提高這些重要技術的普及率。

全球靜脈輸液幫浦市場趨勢

全球靜脈輸液幫浦市場正蓬勃發展，智慧連網輸液幫浦憑藉其先進的技術和互聯功能，正獲得廣泛應用。這些創新設備能夠輔助劑量計算，與電子健康記錄 (EHR) 系統無縫整合，並實現輸液參數的即時監測。這項技術革新對於提升病患安全、最佳化醫療工作流程以及透過遠端監測和調整來減少用藥錯誤至關重要。隨著數位化醫療解決方案的日益普及，醫療機構正擴大採用智慧輸液幫浦作為提高給藥效率和準確性的重要工具。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 二手資料和一手資料方法
• 市場規模估算方法
• 市場假設與限制

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 市場影響指數
• 關鍵投資機會
• 市場吸引力指數
• 市場生態系統
• PESTEL 分析
• 監管環境
• 價值鏈分析
• 專利分析
• 案例研究分析
• 定價分析

全球靜脈輸液幫浦市場規模（依產品分類）（2019-2032 年）

• 正排量輸液泵
• 胰島素輸注泵
• 注射幫浦
• 腸內輸液泵
• 病人自控式鎮痛幫浦（PCA）
• 家用輸液泵
• 其他產品

全球靜脈輸液幫浦市場依疾病分類（2019-2032 年）

• 糖尿病
• 化療
• 小兒科/新生兒科
• 血液學
• 其他

全球靜脈輸液幫浦市場規模（依技術分類）（2019-2032 年）

• 智慧型輸液幫浦
• 傳統輸液幫浦

全球靜脈輸液幫浦市場規模（依價格分佈）（2019-2032 年）

• 經濟實惠的價格分佈
• 中價格分佈
• 優質的

全球靜脈輸液幫浦市場規模（按應用領域分類）（2019-2032 年）

• 醫院和診所
• 居家醫療
• 門診手術中心（ASC）
• 其他

全球靜脈輸液幫浦市場規模（2019-2032 年）

• 北美（按產品、疾病、技術、價格分佈和應用分類）
  • 美國
  • 加拿大
• 歐洲（按產品、疾病、技術、價格分佈和應用分類）
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區（依產品、疾病、技術、價格分佈和應用分類）
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲（按產品、疾病、技術、價格分佈和應用分類）
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 中東和非洲（按產品、疾病、技術、價格分佈和應用分類）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭對手儀錶板

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）

主要企業簡介

• Becton, Dickinson and Company（BD）
• The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
• Baxter International Inc.
• B. Braun SE
• ICU Medical, Inc.
• Fresenius Kabi
• Terumo Corporation
• Vygon SA
• Medtronic plc
• Mindray
• Nipro Corporation
• Trivitron Healthcare
• Moog, Inc.
• Iradimed
• Arcomed AG
• Micrel Medical Devices
• Woo Young Medical
• InfuSystem Holdings, Inc.
• JMS Co., Ltd.
• Eitan Medical
• Plenum Tech Pvt. Ltd.

結論與建議

Global Intravenous Infusion Pump Market size was valued at USD 17.54 Billion in 2024 and is poised to grow from USD 18.94 Billion in 2025 to USD 35.06 Billion by 2033, growing at a CAGR of 8% during the forecast period (2026-2033).

The global intravenous (IV) infusion pump market is witnessing robust growth, primarily driven by the rising incidence of chronic diseases, an expanding elderly population, and innovations in medical technology. These essential devices ensure precise delivery of fluids, medications, and nutrients into patients' bloodstreams. Increasing demand for home healthcare services and the necessity for accurate drug administration in clinical environments are significant market influencers. Additionally, the emphasis on minimizing medication errors and enhancing patient safety further accelerates market expansion. The future of the IV infusion pump sector hinges on the development of user-friendly, connected devices that focus on patient safety and treatment effectiveness. The ongoing integration of data-driven technologies and patient-centric designs is anticipated to shape market trends, meeting the evolving requirements of healthcare professionals and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Infusion Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Infusion Pump Market Segments Analysis

Global Intravenous Infusion Pump Market is segmented by Product, Disease Indication, Technology, Price Range, End Use and region. Based on Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Patient-controlled Analgesia Pumps (PCA), Ambulatory Infusion Pumps and Other Products. Based on Disease Indication, the market is segmented into Diabetes, Chemotherapy, Pediatrics/Neonatology, Hematology and Others. Based on Technology, the market is segmented into Smart Infusion Pumps and Traditional Infusion Pumps. Based on Price Range, the market is segmented into Economical, Mid-Range and Premium. Based on End Use, the market is segmented into Hospitals & Clinics, Home Care, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intravenous Infusion Pump Market

The rising incidence of chronic illnesses like cancer, diabetes, and cardiovascular conditions, along with a worldwide aging demographic, is significantly boosting the demand for intravenous (IV) infusion pumps. These critical devices play a vital role in the precise delivery of medications, fluids, and nutrients to patients undergoing extended treatments, thus enhancing disease management and fostering improved health outcomes. As more individuals seek long-term care solutions, the reliance on effective IV infusion systems continues to grow, highlighting the essential nature of these tools in modern healthcare settings.

Restraints in the Global Intravenous Infusion Pump Market

The global market for intravenous infusion pumps faces significant challenges due to the high costs associated with advanced models. Both the initial purchase price and the ongoing expenses related to calibration, maintenance, and staff training can exert considerable pressure on healthcare budgets. This financial burden poses a significant obstacle for healthcare facilities, particularly in areas with limited resources or constrained financial capabilities. As a result, the adoption of these essential devices may be hindered, impacting the overall quality of patient care in regions struggling with budgetary constraints. A careful consideration of costs will be necessary to enhance accessibility to these critical technologies.

Market Trends of the Global Intravenous Infusion Pump Market

The Global Intravenous Infusion Pump market is experiencing a robust trend towards the adoption of smart and connected infusion pumps, which harness advanced technology and connectivity features. These innovative devices facilitate dose calculation, integrate seamlessly with electronic health records (EHR) systems, and enable real-time monitoring of infusion parameters. This technological evolution is pivotal in enhancing patient safety, optimizing healthcare workflow, and allowing for remote monitoring and adjustments, thereby minimizing medication errors. As digital healthcare solutions increasingly gain traction, healthcare providers are adopting smart infusion pumps as essential tools for improving the efficiency and accuracy of medication administration processes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impact Factor
• Top Investment Pockets
• Market Attractiveness Index
• Market Ecosystem
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Patent Analysis
• Case Study Analysis
• Pricing Analysis

Global Intravenous Infusion Pump Market Size by Product (2019-2032)

• Market Overview
• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Patient-controlled Analgesia Pumps (PCA)
• Ambulatory Infusion Pumps
• Other Products

Global Intravenous Infusion Pump Market Size by Disease Indication (2019-2032)

• Market Overview
• Diabetes
• Chemotherapy
• Pediatrics/Neonatology
• Hematology
• Others

Global Intravenous Infusion Pump Market Size by Technology (2019-2032)

• Market Overview
• Smart Infusion Pumps
• Traditional Infusion Pumps

Global Intravenous Infusion Pump Market Size by Price Range (2019-2032)

• Market Overview
• Economical
• Mid-Range
• Premium

Global Intravenous Infusion Pump Market Size by End Use (2019-2032)

• Market Overview
• Hospitals & Clinics
• Home Care
• Ambulatory Surgical Centers (ASCs)
• Others

Global Intravenous Infusion Pump Market Size (2019-2032)

• North America (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
  • US
  • Canada
• Europe (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, By Disease Indication, By Technology, By Price Range, & By End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Dashboard

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025

Key Company Profiles

• Becton, Dickinson and Company (BD)
  • Company Overview
  • Product Portfolio Overview
  • Financial Overview
  • Key Developments
• The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
• Baxter International Inc.
• B. Braun SE
• ICU Medical, Inc.
• Fresenius Kabi
• Terumo Corporation
• Vygon SA
• Medtronic plc
• Mindray
• Nipro Corporation
• Trivitron Healthcare
• Moog, Inc.
• Iradimed
• Arcomed AG
• Micrel Medical Devices
• Woo Young Medical
• InfuSystem Holdings, Inc.
• JMS Co., Ltd.
• Eitan Medical
• Plenum Tech Pvt. Ltd.

Conclusion & Analyst Recommendations